Key Statistics

  • Affects approximately 1 in 300–1,000 people
  • Peak incidence in postmenopausal women and prepubertal girls
  • Average diagnostic delay of 5+ years
  • 4–6% risk of squamous cell carcinoma if untreated
  • Up to 15–20% of cases occur in males

What Is Lichen Sclerosus?

Lichen sclerosus (LS) is a chronic inflammatory dermatological condition that primarily affects the anogenital skin, though it can appear on any body surface. The condition causes patches of thin, white, wrinkled skin that can be intensely itchy and painful. Over time, untreated LS can lead to scarring, tissue changes, and significant functional impairment including narrowing of the vaginal opening or urethral meatus.1

Despite being relatively common, lichen sclerosus remains underdiagnosed due to patient reluctance to discuss genital symptoms and clinician unfamiliarity with the condition. Research published in the Journal of the American Academy of Dermatology (2023) estimates that many patients see three or more providers before receiving an accurate diagnosis, with the average delay exceeding five years from symptom onset.

The exact cause is not fully understood, but lichen sclerosus is considered an autoimmune condition. It is associated with other autoimmune disorders including thyroid disease, vitiligo, and pernicious anemia. Genetic susceptibility, hormonal factors, and local tissue damage may all contribute to disease development and progression.

Signs and Symptoms

Lichen sclerosus presents with a range of symptoms that can vary significantly between individuals. Some patients experience severe discomfort while others may be asymptomatic in early stages:

  • Intense itching (pruritus): Often the most distressing symptom, itching can be severe enough to disrupt sleep and daily activities. Nocturnal itching is particularly common
  • White, shiny patches: Characteristic porcelain-white plaques that may appear crinkled or parchment-like on the affected skin
  • Pain and soreness: Burning, stinging, or raw sensations, especially during urination, sexual activity, or bowel movements
  • Skin fragility: The affected skin becomes thin and tears easily, leading to painful fissures and purpura (bruising)
  • Dyspareunia: Pain during sexual intercourse due to tissue thinning, fissuring, and architectural changes
  • Scarring and fusion: Progressive scarring can cause fusion of the labia minora, burial of the clitoris, and narrowing of the introitus
  • Urinary symptoms: Dysuria, altered urinary stream, or difficulty voiding due to meatal stenosis
  • Constipation: Perianal involvement can cause painful defecation, leading to functional constipation particularly in children

Diagnosis and Evaluation

Accurate diagnosis of lichen sclerosus requires clinical expertise and sometimes histological confirmation. The diagnostic approach includes:

A thorough visual examination by an experienced dermatologist or gynecologist can often establish the diagnosis based on the characteristic white patches and textural changes. The "figure-of-eight" pattern around the vulva and perianal area is a classic finding. Dermoscopy may reveal additional features such as comedo-like openings, structureless white-pink areas, and linear vessels.

Biopsy is recommended when the diagnosis is uncertain, when there is suspicion of malignant transformation, when the condition fails to respond to first-line treatment, or when pigmented areas are present. Histopathology typically shows epidermal atrophy, hydropic degeneration of the basal layer, a homogenized collagen zone in the upper dermis, and a band-like lymphocytic infiltrate beneath the homogenized zone.2

Laboratory evaluation should include thyroid function tests and thyroid antibodies, given the strong association with autoimmune thyroid disease. Complete blood count and vitamin B12 levels may be checked to screen for pernicious anemia. Autoantibody screening can identify coexisting autoimmune conditions.

Treatment Approaches

While there is no cure for lichen sclerosus, effective treatment can control symptoms, prevent progression, and reduce the risk of complications including malignant transformation:

First-Line Therapy

Ultra-potent topical corticosteroids, specifically clobetasol propionate 0.05% ointment, are the gold standard treatment. The British Association of Dermatologists recommends an initial intensive regimen of daily application for one month, alternate days for one month, then twice weekly for one month, followed by a long-term maintenance schedule of once or twice weekly application. Studies show that up to 95% of patients achieve symptom relief with this approach.3

Second-Line Options

  • Topical calcineurin inhibitors: Tacrolimus 0.1% ointment or pimecrolimus 1% cream may be used as steroid-sparing agents, particularly for facial or non-genital disease
  • Topical retinoids: May help in cases resistant to corticosteroids
  • Phototherapy: UVA1 phototherapy has shown benefit in extragenital disease
  • Platelet-rich plasma (PRP): Emerging evidence suggests PRP injections may improve tissue quality and symptoms

Surgical Intervention

Surgery may be necessary to release adhesions, widen the introitus, or address architectural distortion that impairs function. Circumcision is often curative for male genital LS. For women, surgery addresses structural complications but does not treat the underlying disease, and medical therapy must continue postoperatively.

Living with Lichen Sclerosus

Managing lichen sclerosus as a chronic condition requires ongoing attention and self-care strategies:

  • Skin care routine: Use gentle, fragrance-free cleansers. Avoid soap on affected areas. Apply emollients regularly to protect and moisturize the skin barrier
  • Clothing choices: Wear loose-fitting cotton underwear. Avoid tight clothing that creates friction. Consider silk underwear designed for sensitive skin conditions
  • Sexual health: Use generous amounts of preservative-free lubricant. Consider vaginal dilators if narrowing has occurred. Communicate openly with partners about limitations and comfort
  • Psychological support: The chronic nature and intimate location of LS can cause significant psychological distress. Counseling and support groups can be invaluable
  • Monitoring: Regular follow-up examinations are essential. Self-examination monthly for any new lumps, thickened areas, or non-healing sores that could indicate malignant change

Long-Term Outlook and Monitoring

Lichen sclerosus is a lifelong condition in most adults, though childhood LS may resolve at puberty. The most serious long-term risk is the development of vulvar squamous cell carcinoma, estimated at 4–6% in women with vulvar LS. Regular surveillance with a knowledgeable clinician is essential. Consistent use of topical corticosteroids appears to significantly reduce malignancy risk, with one large cohort study showing reduced rates from 5% to less than 1% with compliant treatment.4

With appropriate treatment and monitoring, most patients can achieve good symptom control. Early diagnosis and consistent therapy are associated with better outcomes, less scarring, and improved quality of life. Research into novel treatments including JAK inhibitors and adipose-derived stem cell therapy is ongoing and offers hope for improved future options.

Frequently Asked Questions

Is lichen sclerosus contagious?

No. Lichen sclerosus is not contagious and cannot be spread through sexual contact or any other means. It is an autoimmune-mediated inflammatory condition.

Can lichen sclerosus turn into cancer?

There is a small but significant risk (4–6%) of vulvar squamous cell carcinoma developing in areas affected by LS. Regular monitoring and consistent treatment with topical corticosteroids significantly reduce this risk.

Will I need treatment forever?

Most adults with LS require long-term maintenance therapy, typically with topical corticosteroids applied once or twice weekly. Stopping treatment usually leads to symptom recurrence and disease progression.

Can I still have sexual intercourse?

Many people with LS maintain an active sex life with appropriate management. Using emollients and lubricants, treating active disease, and communicating with your partner can help. If scarring has narrowed the vaginal opening, dilators or surgery may be considered.

References

  1. Kirtschig G. Lichen sclerosus—presentation, diagnosis and management. Dtsch Arztebl Int. 2016;113(19):337–343.
  2. Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018;178(4):839–853.
  3. Chi CC, Kirtschig G, Baldo M, et al. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev. 2011;(12):CD008240.
  4. Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus. JAMA Dermatol. 2015;151(10):1061–1067.
  5. Virgili A, Borghi A, Cazzaniga S, et al. New insights into potential risk factors and associations in genital lichen sclerosus. J Eur Acad Dermatol Venereol. 2017;31(2):255–262.

Related Resources